Literature DB >> 27571913

Molecular diagnosis of opportunistic pericardial infection in a patient treated with adalimumab: the role of next-generation sequencing.

Stefano Poli1, Manola Comar2, Roberto Luzzati3, Gianfranco Sinagra1.   

Abstract

Biological immune-modulator drugs, especially inhibitors of tumor necrosis factor-α, are frequently encountered in modern clinical practice and opportunistic infections are therefore a common concern. Infective pericarditis has been described as a complication of these treatments with possible life-threatening consequences. In similar cases cultures may isolate multiple opportunistic bacteria from the pericardial fluid without specific identification of the responsible germ, representing a problem for targeted antibiotic therapy. We present a case of acute pericarditis evolving in pericardial constriction and cardiac tamponade in a patient treated with adalimumab for psoriatic arthritis overlapping with recurrent polychondritis. Next-generation sequencing allowed the identification of a common oral pathogen as the aetiological agent confirming its role in the identification of species that can be overlooked by common microbiological techniques. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27571913      PMCID: PMC5015141          DOI: 10.1136/bcr-2016-215529

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Bacterial pericarditis: diagnosis and management.

Authors:  Sabine Pankuweit; Arsen D Ristić; Petar M Seferović; Bernhard Maisch
Journal:  Am J Cardiovasc Drugs       Date:  2005       Impact factor: 3.571

2.  Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexate.

Authors:  Cristina Lutman; Gherardo Finocchiaro; Elena Abate; Marco Milo; Pia Morassi; Gianfranco Sinagra
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2014-12       Impact factor: 2.160

3.  Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.

Authors:  Ted R Mikuls; Jeffrey B Payne; Fang Yu; Geoffrey M Thiele; Richard J Reynolds; Grant W Cannon; Jeffrey Markt; David McGowan; Gail S Kerr; Robert S Redman; Andreas Reimold; Garth Griffiths; Mark Beatty; Shawneen M Gonzalez; Debra A Bergman; Bartlett C Hamilton; Alan R Erickson; Jeremy Sokolove; William H Robinson; Clay Walker; Fatiha Chandad; James R O'Dell
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

4.  Complication of etanercept treatment for rheumatoid arthritis--purulent pericarditis caused by a commensal organism.

Authors:  Gemma K Taylor; Louise Elliott; Michael D Sosin; Shiu Shing Soo
Journal:  BMJ Case Rep       Date:  2012-05-08

5.  Coinfection with Fusobacterium nucleatum can enhance the attachment and invasion of Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans to human gingival epithelial cells.

Authors:  Yan Li; Hongmei Guo; Xijun Wang; Yang Lu; Chunyu Yang; Pishan Yang
Journal:  Arch Oral Biol       Date:  2015-06-23       Impact factor: 2.633

Review 6.  Infection and musculoskeletal conditions: Bacterial and opportunistic infections during anti-TNF therapy.

Authors:  Anja Strangfeld; Joachim Listing
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-12       Impact factor: 4.098

7.  Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.

Authors:  J D Greenberg; G Reed; J M Kremer; E Tindall; A Kavanaugh; C Zheng; W Bishai; M C Hochberg
Journal:  Ann Rheum Dis       Date:  2009-04-08       Impact factor: 19.103

Review 8.  Incidence and nature of infectious disease in patients treated with anti-TNF agents.

Authors:  Siba P Raychaudhuri; Caroline T Nguyen; Smriti K Raychaudhuri; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2009-08-27       Impact factor: 9.754

9.  Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis.

Authors:  R G Deshpande; M B Khan; C A Genco
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  Purulent pericardial effusions with pericardial tamponade - diagnosis and treatment issues.

Authors:  C P Petcu; Rodica Dilof; C Bătăiosu; P D Petcu
Journal:  Curr Health Sci J       Date:  2013-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.